Search Results - Jan Serroyen

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses by Sonia Marquez-Martinez, Nadine Salisch, Jan Serroyen, Roland Zahn, Selina Khan

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  2. 2

    Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets by Selina Khan, Nadine C. Salisch, Ana Izquierdo Gil, Satish Boedhoe, Karin Feddes-de Boer, Jan Serroyen, Hanneke Schuitemaker, Roland C. Zahn

    Published in npj Vaccines (2022-11-01)
    Get full text
    Article


  3. 3

    Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform. by Nadine C Salisch, Marija Vujadinovic, Esmeralda van der Helm, Dirk Spek, Lars Vorthoren, Jan Serroyen, Harmjan Kuipers, Hanneke Schuitemaker, Roland Zahn, Jerome Custers, Jort Vellinga

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  4. 4

    Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels by Machteld M. Tiemessen, Laura Solforosi, Liesbeth Dekking, Dominika Czapska-Casey, Jan Serroyen, Nancy J. Sullivan, Ariane Volkmann, Maria Grazia Pau, Benoit Callendret, Hanneke Schuitemaker, Kerstin Luhn, Roland Zahn, Ramon Roozendaal

    Published in Vaccines (2022-08-01)
    Get full text
    Article


  5. 5

    Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge by Leslie van der Fits, Rineke de Jong, Karin Dijkman, Marjolein Heemskerk-van der Meer, Lisanne Tettero, Judith Bonsing, Sophie van Oort, Jan Serroyen, Marianke van Schie, Norbert Stockhofe-Zurwieden, Benoit Callendret, Roland Zahn

    Published in npj Vaccines (2024-11-01)
    Get full text
    Article


  6. 6

    Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscu... by Selina Khan, Sonia Marquez-Martinez, Tim Erkens, Adriaan de Wilde, Lea M. M. Costes, Petra Vinken, Sandra De Jonghe, Wendy Roosen, Chiara Talia, Ronnie Chamanza, Jan Serroyen, Jeroen Tolboom, Roland C. Zahn, Frank Wegmann

    Published in Vaccines (2023-11-01)
    Get full text
    Article


  7. 7

    Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models by Eirikur Saeland, Leslie van der Fits, Renske Bolder, Marjolein Heemskerk-van der Meer, Joke Drijver, Yolinda van Polanen, Cornelis Vaneman, Lisanne Tettero, Freek Cox, Jan Serroyen, Matthew J. Jorgensen, Johannes P. M. Langedijk, Hanneke Schuitemaker, Benoit Callendret, Roland C. Zahn

    Published in npj Vaccines (2023-03-01)
    Get full text
    Article


  8. 8

    The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia by Sonia Marquez-Martinez, Selina Khan, Joan van der Lubbe, Laura Solforosi, Lea M. M. Costes, Ying Choi, Satish Boedhoe, Mieke Verslegers, Marjolein van Heerden, Wendy Roosen, Sandra De Jonghe, Hendy Kristyanto, Veronica Rezelj, Jenny Hendriks, Jan Serroyen, Jeroen Tolboom, Frank Wegmann, Roland C. Zahn

    Published in Vaccines (2024-05-01)
    Get full text
    Article


  9. 9

    A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates by Aneesh Vijayan, Ronald Vogels, Rachel Groppo, Yi Jin, Selina Khan, Mirjam Van Kampen, Sytze Jorritsma, Satish Boedhoe, Miranda Baert, Harry van Diepen, Harmjan Kuipers, Jan Serroyen, Jorge Reyes- del Valle, Ann Broman, Lannie Nguyen, Sayoni Ray, Bader Jarai, Jayant Arora, Michelle Lifton, Benjamin Mildenberg, Georgeanna Morton, Sampa Santra, Tamar R. Grossman, Hanneke Schuitemaker, Jerome Custers, Roland Zahn

    Published in Nature Communications (2024-11-01)
    Get full text
    Article


  10. 10

    Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate by Ramon Roozendaal, Jenny Hendriks, Thierry van Effelterre, Bart Spiessens, Liesbeth Dekking, Laura Solforosi, Dominika Czapska-Casey, Viki Bockstal, Jeroen Stoop, Daniel Splinter, Sarah Janssen, Ben van Baelen, Nadia Verbruggen, Jan Serroyen, Eline Dekeyster, Ariane Volkmann, Yvonne Wollmann, Ricardo Carrion, Luis D. Giavedoni, Cynthia Robinson, Maarten Leyssen, Macaya Douoguih, Kerstin Luhn, Maria Grazia Pau, Jerry Sadoff, An Vandebosch, Hanneke Schuitemaker, Roland Zahn, Benoit Callendret

    Published in npj Vaccines (2020-12-01)
    Get full text
    Article


  11. 11

    Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease by Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan, Liesbeth Dekking, Ella van Huizen, Jessica Vreugdenhil, Ying Choi, Miranda R. M. Baert, Karin Feddes-de Boer, Ana Izquierdo Gil, Marjolein van Heerden, Tim J. Dalebout, Sebenzile K. Myeni, Marjolein Kikkert, Eric J. Snijder, Leon de Waal, Koert J. Stittelaar, Jeroen T. B. M. Tolboom, Jan Serroyen, Leacky Muchene, Leslie van der Fits, Lucy Rutten, Johannes P. M. Langedijk, Dan H. Barouch, Hanneke Schuitemaker, Roland C. Zahn, Frank Wegmann

    Published in npj Vaccines (2021-03-01)
    Get full text
    Article


Search Tools: